Related Experiment Video
Updated: Aug 9, 2026

Development of an In Vitro Assay to Evaluate Contractile Function of Mesenchymal Cells that Underwent Epithelial-Mesenchymal Transition
Published on: June 10, 2016
Connective tissue growth factor is responsible for transforming growth factor-beta-induced peritoneal mesothelial
Cheuk-Chun Szeto1, Kai-Ming Chow, Ka-Bik Lai
1Department of Medicine, Prince of Wales Hospital, The Chinese University of Hong Kong, Shatin, Hong Kong, SAR, China. ccszeto@cuhk.edu.hk
Background:
Previous studies found that transforming growth factor-beta (TGF-beta) induces mesothelial production of connective tissue growth factor (CTGF), which may be downstream mediators of TGF-beta. Since high dose TGF-beta induces apoptosis of peritoneal mesothelial cells (PMC), we study the effect of CTGF blockade in the system of TGF-beta-induced PMC apoptosis.
Method:
We examined the effect of TGF-W in primary culture of rat peritoneal mesothelial cells (PMC). PMC apoptosis was studied by flow cytometry. The effect of CTGF was blocked by antibody and short-interfering RNA (siRNA). Expression of apoptotic gene was studied by real-time polymerase chain reaction.
Result:
In cultured unstimulated rat PMC, there is a low but definite incidence of spontaneous apoptosis. Stimulation with TGF-beta 50 pg/ml induces an upregulation of apoptotic gene BAX expression and a downregulation of anti-apoptotic gene BCL-2L expression, and a 4-fold increase in PMC apoptosis. The effect of TGF-beta-induced PMC apoptosis was partly prevented by antibody against CTGF, and completely abolished by CTGF-specific siRNA, while CTGF-blockade by siRNA had no effect on PMC necrosis. CTGF silencing by siRNA prevented the down-regulation of BCL-2L expression induced by TGF-beta, had no effect on the BAX expression.
Conclusion:
Our results indicate that CTGF is an important downstream mediator of TGF-beta-induced PMC apoptosis.
Insights
Connective tissue growth factor (CTGF) mediates transforming growth factor-beta (TGF-beta)-induced apoptosis in peritoneal mesothelial cells (PMC). Blocking CTGF with siRNA prevents TGF-beta-induced PMC apoptosis, highlighting CTGF as a key downstream mediator.
Area of Science:
- Cell Biology
- Molecular Biology
- Renal Physiology
Background:
- Transforming growth factor-beta (TGF-beta) stimulates peritoneal mesothelial cells (PMC) to produce connective tissue growth factor (CTGF).
- High doses of TGF-beta can induce apoptosis in PMC.
- CTGF is potentially a downstream mediator of TGF-beta's effects.
Purpose of the Study:
- To investigate the role of CTGF in TGF-beta-induced apoptosis of PMC.
- To determine if CTGF blockade can prevent TGF-beta-induced PMC apoptosis.
Main Methods:
- Primary culture of rat PMC.
- Flow cytometry to assess apoptosis.
- CTGF blockade using antibodies and short-interfering RNA (siRNA).
- Real-time polymerase chain reaction to analyze apoptotic gene expression (BAX, BCL-2L).
Main Results:
- TGF-beta upregulated BAX and downregulated BCL-2L, increasing PMC apoptosis fourfold.
- Antibody-mediated CTGF blockade partially prevented TGF-beta-induced apoptosis.
- CTGF-specific siRNA completely abolished TGF-beta-induced PMC apoptosis, without affecting necrosis.
- CTGF silencing prevented TGF-beta-induced downregulation of BCL-2L but not BAX expression.
Conclusions:
- CTGF is a critical downstream mediator in the pathway of TGF-beta-induced PMC apoptosis.
- Targeting CTGF may represent a therapeutic strategy for conditions involving TGF-beta-mediated mesothelial cell apoptosis.
More Related Videos
Related Concept Videos
TGF - β Signaling Pathway
Mitogens and the Cell Cycle
Introduction to Fibroblasts
Liver Regeneration
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are large...
Healing I: Introduction
Regulation of Angiogenesis and Blood Supply

